‼️ Catch up on the week's top headlines and what they mean for pharmacy on the newest episode of qAM Highlights! Trump’s got tariffs, Mehmet Oz is now in charge at CMS (yes, that Dr. Oz), and PBM reform is heating up in Congress and the courts. Plus, big moves in Florida and Arkansas could shake up how PBMs play the game. 🎧 Listen to the Independent Rx Forum wherever you get your podcasts or at ncpa.org/rxforumpodcast. (fb)

🚨The new Medicare Part D Final Rule for CY 2026 rule just came out. NCPA is analyzing it now and we will have more to say next week. In the meantime, we have included a link to webpage webpage that houses our most recent statements on the issue. We have been urging CMS and the administration to address what we believe are egregious flaws in the Medicare Drug Price Negotiation program which, according to our research, will cause pharmacies to lose on average $11,000 per week in lost cash flow and cost pharmacies on average $43,000 per year in lost revenue. https://bit.ly/43YQHrZ (fb)